Dr. Kevin Timothy Solt

D.D.S. | Dentist



  
  1535 44th St Sw Ste 200, Wyoming
  Michigan, 49509

  616-531-0630    Maps & Directions
Dr. Kevin Timothy Solt is a Wyoming, Michigan based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1535 44th St Sw Ste 200, Wyoming. Patients can reach him at 616-531-0630.
Dr. Kevin Timothy Solt is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Kevin Timothy Solt speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Kevin Timothy Solt
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:1535 44th St Sw Ste 200, Wyoming,
Michigan, 49509
Phone:616-531-0630
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 0446550487
Enrollment ID: I20151124001936
NPI Number: 1366882755
NPI Enumeration Date: 28 Jun, 2013
NPI Last Update On: 09 Jul, 2018

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 1535 44th St Sw Ste 200,
Wyoming, Michigan
Zip: 49509-4481
Phone Number: 616-531-0630
Patients can reach Dr. Kevin Timothy Solt at 1535 44th St Sw Ste 200, Wyoming, Michigan or can call to book an appointment on 616-531-0630. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: